13-08-2024 |
AH |
|
CTSO |
Cytosorbents |
55.00 |
-0.08 |
-0.09 |
0.00 |
Cytosorbents GAAP EPS of -$0.08 beats by $0.02, revenue of $9.9M beats by $0.22M [8/13/2024 4:35 PM] |
0.9665 |
0.07 (7.99%) |
0.95 |
0.06 (6.15%) |
0.70 - 3.01 |
78,888 |
100,000 |
775 |
|
|
09-05-2024 |
AH |
|
CTSO |
Cytosorbents Corporation |
50.61 |
-0.12 |
-0.12 |
-0.17 |
Cytosorbents GAAP EPS of -$0.12 in-line, revenue of $9.8M beats by $0.02M [5/9/2024 4:34 PM] |
0.9318 |
0.12 (15.04%) |
0.84 |
0.03 (3.70%) |
0.78 - 4.29 |
174,455 |
110,000 |
3,840 |
|
|
14-03-2024 |
AH |
|
CTSO |
Cytosorbents Corporation |
44.44 |
-0.12 |
-0.14 |
-0.01 |
Cytosorbents GAAP EPS of -$0.64 misses by $0.02, revenue of $31.09M misses by $6.4M [3/14/2024 5:09 PM] |
0.93 |
-0.04 (-4.11%) |
0.98 |
0.01 (1.04%) |
0.84 - 4.29 |
410,627 |
70,000 |
3,467 |
|
|
09-11-2023 |
AH |
|
CTSO |
Cytosorbents Corporation |
59.00 |
-0.21 |
-0.12 |
-0.28 |
Cytosorbents GAAP EPS of -$0.21 misses by $0.09, revenue of $8.8M misses by $0.52M [11/9/2023 5:02 PM] |
1.28 |
0.02 (1.59%) |
1.31 |
0.05 (3.97%) |
1.03 - 4.59 |
212,365 |
80,000 |
225 |
|
|
01-08-2023 |
AH |
|
CTSO |
Cytosorbents Corporation |
163.51 |
-0.14 |
-0.11 |
-0.25 |
Cytosorbents GAAP EPS of -$0.14 in-line, revenue of $9.4M misses by $0.8M [8/1/2023 4:33 PM] |
3.42 |
-0.21 (-5.66%) |
3.60 |
-0.02 (-0.55%) |
1.03 - 4.59 |
146,261 |
50,000 |
600 |
|
|
02-05-2023 |
AH |
4:15 PM ET (May 2) |
CTSO |
Cytosorbents Corporation |
108.13 |
-0.17 |
-0.13 |
-0.21 |
Cytosorbents GAAP EPS of -$0.17 misses by $0.02, revenue of $9.44M beats by $0.71M [5/2/2023 4:21 PM] |
2.80 |
0.43 (18.14%) |
0.0 |
0.0 (0.00%) |
1.03 - 4.59 |
140,248 |
90,000 |
0 |
|
|
09-03-2023 |
AH |
4:15 PM ET (Mar 9) |
CTSO |
Cytosorbents Corporation |
145.31 |
-0.01 |
-0.17 |
-0.21 |
Cytosorbents GAAP EPS of -$0.75 beats by $0.14, revenue of $29.36M misses by $4.69M [3/9/2023 4:20 PM] |
3.56 |
-0.02 (-0.70%) |
0.0 |
0.0 (0.00%) |
1.03 - 4.59 |
58,980 |
110,000 |
0 |
|
|
03-11-2022 |
AH |
4:15 PM ET (Nov 3) |
CTSO |
Cytosorbents Corporation |
82.36 |
-0.28 |
-0.16 |
-0.15 |
Cytosorbents GAAP EPS of -$0.28 misses by $0.12, revenue of $8.1M misses by $0.42M [11/3/2022 5:02 PM] |
1.64 |
-0.31 (-15.89%) |
1.68 |
-0.27 (-13.85%) |
1.18 - 6.64 |
375,754 |
460,000 |
53,308 |
|
|
02-08-2022 |
AH |
4:15 PM ET (Aug 2) |
CTSO |
Cytosorbents Corporation |
92.79 |
-0.25 |
-0.14 |
-0.11 |
Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M [8/2/2022 4:44 PM] |
2.00 |
-0.33 (-14.32%) |
2.32 |
-0.02 (-0.85%) |
1.69 - 9.80 |
347,477 |
60,000 |
225 |
|
|
03-05-2022 |
AH |
4:15 PM ET (May 3) |
CTSO |
Cytosorbents |
89.00 |
-0.21 |
-0.15 |
0.00 |
Cytosorbents GAAP EPS of -$0.21 misses by $0.06, revenue of $8.69M misses by $1.32M [5/3/2022 4:35 PM] |
2.11 |
-0.07 (-3.21%) |
1.98 |
-0.20 (-9.17%) |
1.80 - 9.80 |
507,584 |
290,000 |
22,287 |
|
|
08-03-2022 |
AH |
4:15 PM ET (Mar 8) |
CTSO |
Cytosorbents Corporation |
168.69 |
-0.21 |
-0.13 |
0.00 |
Cytosorbents reports Q4 results [3/8/2022 4:37 PM] |
3.37 |
-0.38 (-10.13%) |
3.60 |
-0.15 (-4.00%) |
3.18 - 9.80 |
148,854 |
150,000 |
24,470 |
|
|
04-11-2021 |
AH |
4:15 PM ET (Nov 4) |
CTSO |
Cytosorbents Corporation |
252.47 |
-0.15 |
-0.11 |
-0.02 |
Cytosorbents EPS misses by $0.03, beats on revenue [11/4/2021 4:29 PM] |
6.25 |
0.14 (2.29%) |
6.25 |
0.14 (2.29%) |
5.73 - 11.68 |
314,316 |
180,000 |
1,442 |
|
|
03-08-2021 |
AH |
4:15 PM ET (Aug 3) |
CTSO |
Cytosorbents Corporation |
328.43 |
-0.11 |
-0.03 |
-0.08 |
Cytosorbents EPS misses by $0.06, beats on revenue [8/3/2021 4:35 PM] |
7.01 |
-0.24 (-3.37%) |
7.30 |
0.04 (0.55%) |
7.01 - 11.68 |
211,509 |
150,000 |
388 |
|
|
04-05-2021 |
AH |
4:15 PM ET (May 4) |
CTSO |
Cytosorbents Corporation |
392.74 |
-0.10 |
-0.03 |
-0.10 |
Cytosorbents EPS misses by $0.05, misses on revenue [5/4/2021 4:33 PM] |
8.70 |
-0.39 (-4.29%) |
8.50 |
-0.59 (-6.49%) |
7.13 - 11.74 |
450,129 |
220,000 |
7,639 |
|
|
09-03-2021 |
AH |
4:15 PM ET (Mar 9) |
CTSO |
Cytosorbents Corporation |
370.29 |
N/A |
-0.04 |
-0.13 |
Cytosorbents EPS beats by $0.03, beats on revenue [3/9/2021 4:21 PM] |
8.56 |
-0.19 (-2.17%) |
9.15 |
0.40 (4.57%) |
3.60 - 11.74 |
306,589 |
296,352 |
259 |
|
|
04-11-2020 |
AH |
4:15 PM ET (Nov 4) |
CTSO |
Cytosorbents Corporation |
346.99 |
-0.02 |
-0.09 |
-0.21 |
Cytosorbents EPS beats by $0.07, beats on revenue [11/4/2020 4:23 PM] |
8.92 |
0.53 (6.32%) |
8.90 |
0.51 (6.08%) |
3.49 - 11.74 |
460,890 |
282,170 |
5,325 |
|
|
04-08-2020 |
AH |
4:15 PM ET (Aug 4) |
CTSO |
Cytosorbents Corporation |
411.47 |
-0.08 |
-0.08 |
-0.11 |
Cytosorbents EPS in-line, misses on revenue [8/4/2020 4:33 PM] |
9.94 |
0.53 (5.63%) |
9.30 |
-0.11 (-1.17%) |
3.49 - 11.74 |
425,265 |
1,012,793 |
139 |
|
|
05-05-2020 |
AH |
4:15 PM ET (May 5) |
CTSO |
Cytosorbents Corporation |
311.42 |
-0.10 |
-0.14 |
-0.15 |
Cytosorbents EPS beats by $0.05, beats on revenue [5/5/2020 4:19 PM] |
9.31 |
-0.07 (-0.75%) |
10.10 |
0.79 (8.49%) |
3.49 - 10.24 |
471,069 |
835,146 |
9,333 |
|
|